why choose us

First received: May 23, 2024

Clinical Trial: Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atrial Fibrillation

Study Type: INTERVENTIONAL


Official Title: Efficacy of DApagliflozin on REcurrence After Catheter Ablation for Atrial Fibrillation

Brief Summary: This is a single-center, parallel-group, randomized, open-label trial evaluating the effect of 3-month treatment with dapagliflozin 10mg once daily on the recurrence of atrial fibrillation after catheter ablation for atrial fibrillation in patients without diabetes, heart failure, or chronic kidney disease.

Read more